ARTICLE | Company News
Cellzome, GlaxoSmithKline deal
May 21, 2012 7:00 AM UTC
GlaxoSmithKline will acquire the 80.02% of proteomics company Cellzome it does not already own for £61 million ($98 million) in cash. GSK said Cellzome's proteomic mass spectrometry and screening capa...